This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB03174/identifier/chebi/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03174/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03174/identifier/kegg-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03174/identifier/pubchem-compound/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03174/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03174/identifier/drugbank/
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03174
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB03174 n15:DB03174
dcterms:title
Phosphonoacetaldehyde
adms:identifier
n4:18124 n7:DB03174 n11:490 n12:46504576 n13:C03167 n14:POA
n5:IUPAC-Name
n6:271B5617-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B561D-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B561C-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5619-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B561A-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B561B-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5615-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5613-363D-11E5-9242-09173F13E4C5 n6:271B5616-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5614-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5623-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5624-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B561E-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B561F-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5621-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5620-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5622-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5629-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B562B-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B562C-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5628-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5627-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B562A-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5618-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5625-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5626-363D-11E5-9242-09173F13E4C5